PubMed-indexed, rapid publication, peer reviewed #openaccess journal. Impact Factor 4.7. CiteScore 8.6. Part of @AdisJournals.

Chester, England
Joined July 2017
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults. Read the full article here: link.springer.com/article/10…
97
COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States #COVIDー19 Read the full article #OpenAccess here: link.springer.com/article/10…
108
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients #COVIDー19 Read the full article #openaccess here: link.springer.com/article/10…
108
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19: link.springer.com/article/10…
115
Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018: link.springer.com/article/10…
101
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes link.springer.com/article/10…
90
Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19: link.springer.com/article/10…
65
"#Safety, #Tolerability, and #Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers" link.springer.com/article/10… #RespiratorySyncytialVirus #RSV
1
2
169
"Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions" Available #openaccess here: link.springer.com/article/10… #covid19 #infectiousdiseases
90